Aldoxorubicin

A 6-maleimidocaproyl hydrazone derivative prodrug of the anthracycline antibiotic doxorubicin (DOXO-EMCH) with antineoplastic activity. Following intravenous administration, aldoxorubicin binds selectively to the cysteine-34 position of albumin via its maleimide moiety. Doxorubicin is released from the albumin carrier after cleavage of the acid-sensitive hydrazone linker within the acidic environment of tumors and, once located intracellularly, intercalates DNA, inhibits DNA synthesis, and induces apoptosis. Albumin tends to accumulate in solid tumors as a result of high metabolic turnover, rapid angiogenesis, hypervasculature, and impaired lymphatic drainage. Because of passive accumulation within tumors, this agent may improve the therapeutic effects of doxorubicin while minimizing systemic toxicity. (NCI Thesaurus)

YOU MAY ALSO LIKE

Aldosterone-Regulated Sodium Reabsorption Pathway

Sodium transport across the tight epithelia of Na+ reabsorbing tissues such as the distal part of the kidney nephron and colon is…

Aldosterone-Producing Adrenal Cortex Adenoma

An adenoma of the adrenal cortex that produces aldosterone. It may be associated with Conn syndrome. Clinical presentation includes hypertension,…

Aldosterone Receptor Antagonist

A class of agents that act by selectively inhibiting aldosterone receptor activation with diuretic activity. Aldosterone receptor antagonists bind to and block…

Aldosterone Measurement

The determination of the amount of aldosterone hormone present in a sample.

Aldosterone

A steroid hormone made by the adrenal cortex (the outer layer of the adrenal gland). It helps control the balance of water…

Aldose Reductase Inhibitor

Any substance that inhibits aldehyde reductase (aldose reductase), an enzyme that participates in glucose metabolism and osmoregulation. Aldehyde reductase has been implicated…